Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2024.7 | Other Grant/Funding Number | VEHBİ KOÇ FOUNDATION NURSING FUND |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Koç University | OTHER |
Not provided
Not provided
Not provided
Not provided
Aim: This study was conducted to determine the effect of a mobile education program and telephone monitoring developed for patients with implantable cardioverter defibrillators (ICD) on shock anxiety, device acceptance, and self-efficacy.
Method: The study was designed as a single-blind, randomized controlled trial consisting of two phases. In the first phase, the Mobile ICD Education Program (M-ICDEP) was developed. In the second phase, the effectiveness of M-ICDEP was evaluated through a randomized controlled design with 88 ICD patients who attended routine battery check-ups.
Research data were collected through the mobile education program using the Personal Information Form, Florida Shock Anxiety Scale (FSAS), Florida Patient Acceptance Scale (FPAS), and the Self-Efficacy and Outcome Expectations Scales After ICD Implantation (OE-ICD and SB-ICD). Additionally, patients underwent a shock management simulation via M-ICDEP, and their data were assessed using the Shock Management Control Form, which was included in the evaluation of shock anxiety.
Patients in both the intervention and control groups used M-ICDEP for three months. The control group had access only to the brief educational booklet section containing general information, while the intervention group had access to all sections. Patients in the intervention group also received telephone follow-ups during the second, fifth, and eighth weeks of the monitoring period. Data were collected twice: once before the intervention (pre-test) and once in the third month (post-test). Statistical analyses will conducted using the SAS 9.4 software package.
Definition and Importance of the Problem
Implantable cardioverter defibrillators (ICDs) are devices developed to prevent sudden cardiac death resulting from ventricular arrhythmias. According to the 2017 guidelines of the European Heart Rhythm Association, the annual number of ICD implantations per million people is reported to be 107 worldwide and 115 in Turkey. Furthermore, over the past decade, implantation rates have increased by 44% globally and 804.1% in Turkey. Although ICD therapy has been proven to reduce mortality by 28-40% and is more effective than antiarrhythmic drugs, living with an ICD can lead to various psychosocial problems in patients. In particular, anxiety and device adaptation problems are frequently encountered after implantation.
The foreign nature of the ICD, concerns about living dependently on the device, its activation during potentially fatal arrhythmias, and its capability to deliver shocks contribute to increased anxiety. Studies indicate that 44-55% of patients experience shock-related anxiety, with uncertainty regarding the sensation, location, and timing of shocks exacerbating this distress. Additionally, 95% of individuals who have experienced a shock develop anxiety. Anxiety and shock experiences can hinder device acceptance, adversely affecting patients' daily lives. It has been reported that individuals struggling with device acceptance exhibit lower levels of self-efficacy and that self-efficacy plays a crucial psychological role in disease adaptation. Consequently, assessing patients' self-efficacy is of significant importance.
Adequate patient education, telephone follow-ups, and continuous care have been shown to enhance device acceptance and self-efficacy. Despite the recognized importance of patient education and follow-up, 97% of ICD patients report needing further education and monitoring, suggesting a gap in the provision of necessary training.
Currently, innovative and interactive educational methods, such as mobile health applications and simulation techniques, are widely used for patient education. Mobile applications facilitate easy access to information, while simulation methods provide a realistic learning environment by allowing patients to experience real-life scenarios. While international literature includes studies on the use of mobile health applications for ICD patient monitoring, no studies have been identified that apply a mobile education program. Therefore, this study is expected to contribute innovatively to the literature by providing a realistic learning environment through a mobile education program incorporating different algorithms and a shock management simulation. Additionally, it is hypothesized that mobile education programs and telephone monitoring may improve patients' shock anxiety, device acceptance, and self-efficacy levels.
---
Aim of the Study
This study aims to determine the effect of a mobile education program and telephone monitoring developed for ICD patients on shock anxiety, device acceptance, and self-efficacy. It has been designed as a single-blind, randomized controlled trial consisting of two phases. The first phase involves the development of the mobile education program, while the second phase aims to evaluate the impact of the program on patients' shock anxiety, device acceptance, and self-efficacy.
The research hypotheses are formulated as follows:
Compared to the control group, ICD patients in the intervention group who receive the mobile education program and telephone monitoring will experience:
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| The group of mobile education programe | Experimental | The intervention group consists of 44 patients attending routine ICD follow-ups. Patients completed a pre-test before the intervention and a post-test at 12 weeks via M-ICDEP. Data were collected using FSAS, FPAS, OE-ICD, and SB-ICD scales on M-ICDEP. A shock management simulation was conducted at both pre-and post-tests, evaluated with the Shock Management Control Form, and added to shock anxiety data. The intervention group used M-ICDEP anytime during the 3-month follow-up, which includes three sections: education, summary information, and shock management simulation. The program aimed to reduce shock-related anxiety, increase device acceptance, and enhance self-efficacy. Telephone follow-ups were conducted in the 2nd, 5th, and 8th weeks, evaluating patients using the Telephone Calls Monitoring Form. The information shared during these calls was continued within the training program's scope, ensuring consistent reinforcement of the content. |
|
| Standard Treatment Group | Active Comparator | The control group consists of 44 patients attending routine ICD follow-ups. Patients completed a pre-test before the intervention and a post-test at 12 weeks via M-ICDEP. Data were collected using FSAS, FPAS, OE-ICD, and SB-ICD scales on M-ICDEP. A shock management simulation was conducted at both pre-and post-tests, evaluated with the Shock Management Control Form, and added to shock anxiety data. The control group used M-ICDEP, which includes only one section: summary information, anytime during the 3-month follow-up. The program aimed to reduce shock-related anxiety, increase device acceptance, and enhance self-efficacy. Routine outpatient follow-up was continued for the control group without any other intervention. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| The mobile training program and telephone follow-ups | Other | The study had three phases: pre-test, implementation, and post-test. Data were collected twice, before the intervention and in the third month, using validated scales and a shock management simulation via the mobile training program (M-ICDEP). M-ICDEP included three sections: an educational section, a two-page summary, and a shock management simulation. All sections were shared with the intervention group. After the pre-test, intervention group patients could log in to M-ICDEP anytime using their email and password, accessing content repeatedly during the three-month follow-up. The researcher conducted telephone follow-ups in the second, fifth, and eighth weeks, evaluating patients using the Telephone Calls Monitoring Form. The information given to the patients during the telephone conversation was continued within the limited of the training program prepared within the scope of M-ICDEP. |
| Measure | Description | Time Frame |
|---|---|---|
| Shock anxiety level | Shock anxiety is measured using the Florida Shock Anxiety Scale (FSAS), which includes 10 items. Scores range from 5 to 50. Higher scores indicate higher levels of shock-related anxiety. | three month |
| The device acceptance levels | Device acceptance is evaluated with the Florida Patient Acceptance Scale (FPAS), which contains 18 items. The total score ranges from 15 to 75. Higher scores reflect greater acceptance of the implanted cardioverter defibrillator. | three month |
| Self-efficacy and outcome expectation levels | Self-efficacy and outcome expectations are assessed using the Self-Efficacy and Outcome Expectations Scale, based on the ICD Internet Intervention model. It has two subscales: self-efficacy (16 items) and outcome expectations (7 items). The total score ranges from 7 to 195. Higher scores in both subscales indicate higher self-efficacy and more positive outcome expectations. | three month |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mediha SERT GÖKÇEBEL, Researcher | Akdeniz University | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Akdeniz University | Antalya | Konyaaltı | 07070 | Turkey (Türkiye) |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 38176770 | Background | Zipes DP. First conclusive evidence that the implantable cardioverter-defibrillator reduces total mortality compared with drugs. Heart Rhythm. 2024 Jan;21(1):4-5. doi: 10.1016/j.hrthm.2023.09.025. No abstract available. | |
| 22580627 | Background | Wilson MH, Engelke MK, Sears SF, Swanson M, Neil JA. Disease-specific quality of life-patient acceptance: racial and gender differences in patients with implantable cardioverter defibrillators. J Cardiovasc Nurs. 2013 May-Jun;28(3):285-93. doi: 10.1097/JCN.0b013e31824e072e. |
| Label | URL |
|---|---|
| American Heart Association (AHA). (2022a). Devices that may ınterfere with ICDs and pacemakers | View source |
Not provided
Individual participant data (IPD) will not be shared; however, summary statistics (mean, standard deviation, frequencies, etc.) will be included in the thesis and relevant publications
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Nov 19, 2025 | |
| Reset | Dec 10, 2025 |
Not provided
Not provided
Not provided
Not provided
All patients were administered a mobile education program, and the groups to which the patients belonged were not disclosed, ensuring that the patients were blinded. The aim was to achieve single blinding by ensuring that participants were unaware of which group they were assigned to. Additionally, it was planned to minimize bias by not providing information to the person conducting the statistical analysis.
|
| Only a two-page summary section of M-ICDEP | Other | The study had three phases: pre-test, implementation, and post-test. Data were collected twice, before the intervention and in the third month, using validated scales and a shock management simulation via the mobile training program (M-ICDEP). M-ICDEP included three sections: an educational section, a two-page summary, and a shock management simulation. Only a two-page summary section were shared with the control group. After the pre-test, control group patients could log in to M-ICDEP anytime using their email and password, accessing the summary section repeatedly during the three-month follow-up. Routine outpatient follow-up was continued for the control group without any other intervention. |
|
| 23429935 | Background | Tsuji Y, Heijman J, Nattel S, Dobrev D. Electrical storm: recent pathophysiological insights and therapeutic consequences. Basic Res Cardiol. 2013 Mar;108(2):336. doi: 10.1007/s00395-013-0336-2. Epub 2013 Feb 21. |
| 31672781 | Background | Steiner JM, Bernacki G, Kirkpatrick J. My guardian angel: patients' fears and desires related to discussing implantable cardioverter-defibrillator deactivation. Heart. 2020 Feb;106(3):168-169. doi: 10.1136/heartjnl-2019-315935. Epub 2019 Oct 31. No abstract available. |
| 21923008 | Background | Sportsman S, Schumacker RE, Hamilton P. Evaluating the impact of scenario-based high-fidelity patient simulation on academic metrics of student success. Nurs Educ Perspect. 2011 Jul-Aug;32(4):259-65. doi: 10.5480/1536-5026-32.4.259. |
| 19563356 | Background | Sears SF, Matchett M, Conti JB. Effective management of ICD patient psychosocial issues and patient critical events. J Cardiovasc Electrophysiol. 2009 Nov;20(11):1297-304. doi: 10.1111/j.1540-8167.2009.01526.x. Epub 2009 Jun 26. |
| 11124721 | Background | Pavia S, Wilkoff B. The management of surgical complications of pacemaker and implantable cardioverter-defibrillators. Curr Opin Cardiol. 2001 Jan;16(1):66-71. doi: 10.1097/00001573-200101000-00010. |
| 24102743 | Background | Morken IM, Bru E, Norekval TM, Larsen AI, Idsoe T, Karlsen B. Perceived support from healthcare professionals, shock anxiety and post-traumatic stress in implantable cardioverter defibrillator recipients. J Clin Nurs. 2014 Feb;23(3-4):450-60. doi: 10.1111/jocn.12200. Epub 2013 Sep 17. |
| 21707667 | Background | Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009--a World Society of Arrhythmia's project. Pacing Clin Electrophysiol. 2011 Aug;34(8):1013-27. doi: 10.1111/j.1540-8159.2011.03150.x. Epub 2011 Jun 27. |
| 31891421 | Background | Mattsson G, Magnusson P. Long-term follow-up of implantable cardioverter defibrillator patients with regard to appropriate therapy, complications, and mortality. Pacing Clin Electrophysiol. 2020 Feb;43(2):245-253. doi: 10.1111/pace.13869. Epub 2020 Jan 22. |
| 21077915 | Background | Marcus GM, Chan DW, Redberg RF. Recollection of pain due to inappropriate versus appropriate implantable cardioverter-defibrillator shocks. Pacing Clin Electrophysiol. 2011 Mar;34(3):348-53. doi: 10.1111/j.1540-8159.2010.02971.x. Epub 2010 Nov 15. |
| 15136777 | Background | Lemon J, Edelman S, Kirkness A. Avoidance behaviors in patients with implantable cardioverter defibrillators. Heart Lung. 2004 May-Jun;33(3):176-82. doi: 10.1016/j.hrtlng.2004.02.005. |
| 16784427 | Background | Kuhl EA, Dixit NK, Walker RL, Conti JB, Sears SF. Measurement of patient fears about implantable cardioverter defibrillator shock: an initial evaluation of the Florida Shock Anxiety Scale. Pacing Clin Electrophysiol. 2006 Jun;29(6):614-8. doi: 10.1111/j.1540-8159.2006.00408.x. |
| 37694212 | Background | Khani SAG, Matourypour P, Haghjoo M, Zakerimoghadam M. The Effect of Continuous Care Program on the Self-Efficacy of Patients with Implantable Cardioverter Defibrillator: A Randomized Control Trial. Iran J Nurs Midwifery Res. 2023 Jul 24;28(4):455-460. doi: 10.4103/ijnmr.ijnmr_467_21. eCollection 2023 Jul-Aug. |
| 37124375 | Background | Heidari M, Harandi PN, Moghaddasi J, Kheiri S, Azhari A. Effect of Home-Based Cardiac Rehabilitation Program on Self-Efficacy of Patients With Implantable Cardioverter Defibrillator. SAGE Open Nurs. 2023 Apr 24;9:23779608231166473. doi: 10.1177/23779608231166473. eCollection 2023 Jan-Dec. |
| 22381924 | Background | Hacihasanoglu R, Gozum S, Capik C. Validity of the Turkish version of the medication adherence self-efficacy scale-short form in hypertensive patients. Anadolu Kardiyol Derg. 2012 May;12(3):241-8. doi: 10.5152/akd.2012.068. Epub 2012 Mar 2. |
| 11297981 | Background | Glikson M, Friedman PA. The implantable cardioverter defibrillator. Lancet. 2001 Apr 7;357(9262):1107-17. doi: 10.1016/S0140-6736(00)04263-X. |
| 17179461 | Background | Gehi AK, Mehta D, Gomes JA. Evaluation and management of patients after implantable cardioverter-defibrillator shock. JAMA. 2006 Dec 20;296(23):2839-47. doi: 10.1001/jama.296.23.2839. |
| 21951323 | Background | Flemme I, Johansson I, Stromberg A. Living with life-saving technology - coping strategies in implantable cardioverter defibrillators recipients. J Clin Nurs. 2012 Feb;21(3-4):311-21. doi: 10.1111/j.1365-2702.2011.03847.x. Epub 2011 Sep 26. |
| 15136779 | Background | Dougherty CM, Pyper GP, Frasz HA. Description of a nursing intervention program after an implantable cardioverter defibrillator. Heart Lung. 2004 May-Jun;33(3):183-90. doi: 10.1016/j.hrtlng.2004.01.003. |
| 17693214 | Background | Dougherty CM, Johnston SK, Thompson EA. Reliability and validity of the self-efficacy expectations and outcome expectations after implantable cardioverter defibrillator implantation scales. Appl Nurs Res. 2007 Aug;20(3):116-24. doi: 10.1016/j.apnr.2007.04.004. |
| 15828880 | Background | Burns JL, Serber ER, Keim S, Sears SF. Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey. J Cardiovasc Electrophysiol. 2005 Apr;16(4):384-90. doi: 10.1046/j.1540-8167.2005.40134.x. |
| 22292865 | Background | Brink E, Alsen P, Herlitz J, Kjellgren K, Cliffordson C. General self-efficacy and health-related quality of life after myocardial infarction. Psychol Health Med. 2012;17(3):346-55. doi: 10.1080/13548506.2011.608807. Epub 2012 Jan 31. |
| 36749003 | Background | Barisone M, Ghirotto L, Hayter M, Molin AD, Hendriks J, Jennings C. Improving the experience of patients living with an implantable cardioverter defibrillator. Eur J Cardiovasc Nurs. 2023 Apr 12;22(3):e21-e24. doi: 10.1093/eurjcn/zvad020. No abstract available. |
| 20048212 | Background | Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, Masoudi FA, Okum EJ, Wilson WR, Beerman LB, Bolger AF, Estes NA 3rd, Gewitz M, Newburger JW, Schron EB, Taubert KA; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; Council on Cardiovascular Disease in Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Interdisciplinary Council on Quality of Care; American Heart Association. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010 Jan 26;121(3):458-77. doi: 10.1161/CIRCULATIONAHA.109.192665. Epub 2010 Jan 4. |
| 31327518 | Background | Ayyaswami V, Padmanabhan DL, Crihalmeanu T, Thelmo F, Prabhu AV, Magnani JW. Mobile health applications for atrial fibrillation: A readability and quality assessment. Int J Cardiol. 2019 Oct 15;293:288-293. doi: 10.1016/j.ijcard.2019.07.026. Epub 2019 Jul 10. |
| 32832716 | Background | Ammannaya GKK. Implantable cardioverter defibrillators - the past, present and future. Arch Med Sci Atheroscler Dis. 2020 Jul 11;5:e163-e170. doi: 10.5114/amsad.2020.97103. eCollection 2020. |
| Background | Altıkardeş ZA, Bajgora M, Sarıkaya U, Doğan B, Fak AS. Yeni bir yaklaşımla genç bireylerde kalp sağlığı takibi için web ve mobil uygulama geliştirilmesi. International Journal of Advances in Engineering and Pure Sciences. 2019;31(4):328-335. |
| 29097296 | Background | Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018 Oct 2;72(14):e91-e220. doi: 10.1016/j.jacc.2017.10.054. Epub 2018 Aug 16. No abstract available. |
| Background | Alkan H. İmplante Edilebilen Kardiyoverter Defibrilatör Hastalarında Psikososyal Faktörlerin İncelenmesi. İ.Ü. Sağlık Bilimleri Enstitüsü, Doktora Tezi, 2014, İstanbul (Danışman: Prof. Dr. Nuray Enç). |
| Background | Akay B, Oğuz S. The effect of education, telephone monitoring on self-efficacy and shock anxiety of ımplantable cardioverter defibrillator patients. Clinical and Experimental Health Sciences, 2023;13(4):855-862. |
| 28180011 | Background | Abbasi M, Negarandeh R, Norouzadeh R, Shojae Mogadam AR. The Challenges of Living With an Implantable Cardioverter Defibrillator: A Qualitative Study. Iran Red Crescent Med J. 2016 Jun 22;18(10):e25158. doi: 10.5812/ircmj.25158. eCollection 2016 Oct. |
| American Heart Association. (AHA) (2022b). Implantable cardioverter defibrillator (ICD) | View source |
| American Heart Association. (AHA) (2022c). Living with your ımplantable cardioverter defibrillator (ICD) | View source |
| NHLBI- National Heart, Lung, and Blood Institute, Defibrillators | View source |
| WHO, We Are Social \& Hootsuite. Digital 2022 global overwiev report. 2022 | View source |
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Nov 19, 2025 | Dec 10, 2025 |
| ID | Term |
|---|---|
| D010342 | Patient Acceptance of Health Care |
| D012770 | Shock, Cardiogenic |
| ID | Term |
|---|---|
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
| D001519 | Behavior |
| D009203 | Myocardial Infarction |
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D014652 | Vascular Diseases |
| D007238 | Infarction |
| D007511 | Ischemia |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D009336 | Necrosis |
| D012769 | Shock |
Not provided
Not provided